Intimate Partner Violence (IPV)Screening in Health Care Clinics in Rural South Carolina

Partner Abuse Clinical Trial

Official title:

IPV Screening in Health Care Clinics in Rural South Carolina

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00164567
• Other study ID #: CDC-NCIPC-3142
• Secondary ID: US4/CCU419014
• Status: Completed
• Phase: Phase 2
• First received: September 12, 2005
• Last updated: October 22, 2009

Study information

• Verified date: October 2009
• Source: Centers for Disease Control and Prevention
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to implement universal screening for intimate partner violence (IPV) and to test two clinic-based interventions for women who screen positive for current or recent IPV. The study population will be implemented in Pee Dee region of the state of South Carolina and will include primarily low-income women who seek care at selected primary health care clinics in the region.

In this study, all women 18 and older receiving care at selected primary care clinics will be offered screening for IPV annually. Clinicians will use a structured screening tool to assess physical, sexual, and psychological IPV in a current relationship (IPV+) or IPV experienced by the woman in the past five years (Recent IPV). Clinics will be randomly assigned to implement a clinic-based intervention for women who screen positive for current or recent IPV. Two interventions will be implemented using a factorial design. In the Empowerment-Focused Patient Education Intervention, clinicians will conduct a 7-session intervention focusing on the health and well-being of the woman and attempt to link women's IPV experience with their health. In the IPV Services Intervention, IPV Specialists who are trained advocates from the Pee Dee Coalition Against Domestic and Sexual Assault (PDC) will be based in the clinic to (a) counsel women about IPV including safety planning, (b) provide linkages to PDC services, and (c) link women to clinic-based support groups developed specifically for this project.

We hypothesize the intervention(s) will change (a) clinician screening, referral, and IPV documentation patterns, (b) clinician IPV knowledge and perceived skills in working with women who have experienced IPV and their children (c) women's help-seeking behaviors, risk of poor mental and physical health, and (d) women's risk of subsequent IPV victimization. To evaluate these outcomes, we will survey clinicians and prospectively follow a group of consenting IPV+ women (N=300 in each intervention arm) to assess changes in their help-seeking, health behavior and status, IPV experience over two-years of follow-up.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1200
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• female

• 18 - 65 years

• must screen positive for partner abuse

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Partner Abuse

Intervention

Behavioral:
• Onsite IPV specialist

• Empowerment focused intervention

Locations

Country	Name	City	State
United States	Care South clinics (Various)	Hartsville	South Carolina

Sponsors (6)

Lead Sponsor	Collaborator
Centers for Disease Control and Prevention	Care South, Inc., Pee Dee Coalition, The University of Texas Health Science Center, Houston, University of North Carolina, Chapel Hill, University of South Carolina

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	help-seeking
Primary	physical health
Primary	Psychological health
Secondary	revictimization from partner violence
Secondary	child behaviors